Fluence Stands by its Work on the Diablo Plant, and Will Vigorously Pursue the Payments it is Owed for its Work and Dispute the Allegations in the Counterclaim Filed by the Operator of the Plant 21-12-2023, 04:25

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference 25-10-2024, 17:00

Now Is the Time to Get Business Ready for Sale, says M&A 10-03-2023, 00:19